Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2003 | 01-2003 | 10-2002 | 07-2002 | 04-2002 | |
| Sales | 167 | 220 | 323 | 0 | 539 |
| Gross Profit | 167 | 220 | 323 | N/A | 539 |
| Operating Expenses | 19,402 | 20,997 | 21,918 | 0 | 18,338 |
| Operating Income | -19,235 | -20,777 | -21,595 | N/A | -17,799 |
| Interest Expense | 1,930 | 1,867 | 1,927 | 0 | 1,927 |
| Other Income | 1,191 | 1,662 | 1,882 | 0 | 2,621 |
| Pre-tax Income | -19,974 | -20,982 | -21,640 | 0 | -17,105 |
| Income Tax | -196 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -19,778 | -20,982 | -21,640 | N/A | -17,105 |
| Net Income Discontinuous | N/A | -483 | N/A | N/A | N/A |
| Net Income | $-19,778 | $-21,465 | $-21,640 | $N/A | $-17,105 |
| EPS Basic Total Ops | -0.27 | -0.30 | -0.30 | N/A | -0.24 |
| EPS Basic Continuous Ops | -0.27 | -0.29 | -0.30 | N/A | -0.24 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.27 | -0.30 | -0.30 | N/A | -0.24 |
| EPS Diluted Continuous Ops | -0.27 | -0.29 | -0.30 | N/A | -0.24 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | N/A | N/A | N/A |
| EBITDA(a) | $-18,025 | $-19,210 | $-20,716 | $N/A | $-15,855 |